03. Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) Administered as a Booster Dose in Adults and Adolescents Vaccinated Against Meningococcal Disease 3 - 6 Years Earlier

BACKGROUND: Booster doses of meningococcal conjugate vaccines may induce long-term protection against invasive meningococcal disease. MenACYW-TT [MenQuadfi(®)] is a quadrivalent meningococcal conjugate vaccine, licensed for use in ages 2 years and older in USA. The vaccine is also licensed in ages 1...

Descripción completa

Detalles Bibliográficos
Autores principales: Peterson, James, Deseda, Carmen, Julien, Katie, Zambrano, Betzana, Áñez, Germán, Jiayuan, Sue, Pan, Judy, Arroum, Habiba, Varghese, Kucku, Jordanov, Emilia, Dhingra, Mandeep S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644932/
http://dx.doi.org/10.1093/ofid/ofab466.206

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644932/
http://dx.doi.org/10.1093/ofid/ofab466.206

Ejemplares similares